{"id":"https://openalex.org/W7010444935","doi":null,"title":"Intratumorale gentransfer van immunomodulatoire antilichaamcombinaties: een preklinische proof-of-concept studie","display_name":"Intratumorale gentransfer van immunomodulatoire antilichaamcombinaties: een preklinische proof-of-concept studie","alternate_titles":[],"publication_year":2021,"publication_date":"2021-11-19","ids":{"openalex":"https://openalex.org/W7010444935"},"language":"en","primary_location":{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/683645","doi":null,"is_oa":true,"landing_page_url":"https://lirias.kuleuven.be/handle/123456789/683645","pdf_url":"https://lirias.kuleuven.be/retrieve/7c803b0a-f250-4d5c-a667-18b943422303","source":{"id":"https://openalex.org/S4306401954","display_name":"Lirias (KU Leuven)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I99464096","host_organization_name":"KU Leuven","host_organization_lineage":["https://openalex.org/I99464096"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/doctoralThesis"},"parent_works":[],"lineage":["https://openalex.org/W7010444935"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://lirias.kuleuven.be/retrieve/7c803b0a-f250-4d5c-a667-18b943422303","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040803680","display_name":"Liesl Jacobs","orcid":"https://orcid.org/0000-0001-6259-9467","observed_orcids":["https://orcid.org/0000-0001-6259-9467"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jacobs, Liesl","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven","institution_ids":["https://openalex.org/I99464096"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5040803680"],"corresponding_institution_ids":["https://openalex.org/I99464096"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.39160001277923584,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.39160001277923584,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.28690001368522644,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.27000001072883606,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/intratumoral-gene-transfer","display_name":"intratumoral gene transfer","score":0.890999972820282},{"id":"https://openalex.org/keywords/plasmid-dna","display_name":"plasmid DNA","score":0.8410000205039978},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8090000152587891},{"id":"https://openalex.org/keywords/anti-ctla-4","display_name":"anti-CTLA-4","score":0.8420000076293945},{"id":"https://openalex.org/keywords/anti-pd-1-antibody","display_name":"anti-PD-1","score":0.9990000128746033},{"id":"https://openalex.org/keywords/electroporation","display_name":"electroporation","score":0.8659999966621399},{"id":"https://openalex.org/keywords/gene-electrotransfer","display_name":"gene electrotransfer","score":0.6959999799728394},{"id":"https://openalex.org/keywords/mc38-colon-carcinoma","display_name":"MC38 colon carcinoma","score":0.5490000247955322},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.527999997138977},{"id":"https://openalex.org/keywords/t-cell-proliferation","display_name":"T cell proliferation","score":0.37700000405311584},{"id":"https://openalex.org/keywords/immune-related-toxicity","display_name":"immune-related toxicity","score":0.4350000023841858},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.5}],"concepts":[{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6085000038146973},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5575000047683716},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5475999712944031},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.532800018787384},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.52920001745224},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.5180000066757202},{"id":"https://openalex.org/C135983454","wikidata":"https://www.wikidata.org/wiki/Q2790163","display_name":"Gene delivery","level":4,"score":0.4683000147342682},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.46619999408721924},{"id":"https://openalex.org/C54009773","wikidata":"https://www.wikidata.org/wiki/Q1429031","display_name":"Transfection","level":3,"score":0.46219998598098755},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4503999948501587},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4189000129699707},{"id":"https://openalex.org/C195856716","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"Naked DNA","level":4,"score":0.41609999537467957},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3903999924659729},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.376800000667572},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3718000054359436},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.36169999837875366},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.34950000047683716},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3027999997138977},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.29739999771118164},{"id":"https://openalex.org/C2777371288","wikidata":"https://www.wikidata.org/wiki/Q410130","display_name":"Interleukin 2","level":3,"score":0.2939000129699707},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.28130000829696655},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2694999873638153},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.2678000032901764},{"id":"https://openalex.org/C2779261636","wikidata":"https://www.wikidata.org/wiki/Q7003054","display_name":"Neutralizing antibody","level":3,"score":0.26190000772476196},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.25099998712539673},{"id":"https://openalex.org/C90375314","wikidata":"https://www.wikidata.org/wiki/Q3537484","display_name":"Adoptive cell transfer","level":4,"score":0.2506999969482422}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/683645","doi":null,"is_oa":true,"landing_page_url":"https://lirias.kuleuven.be/handle/123456789/683645","pdf_url":"https://lirias.kuleuven.be/retrieve/7c803b0a-f250-4d5c-a667-18b943422303","source":{"id":"https://openalex.org/S4306401954","display_name":"Lirias (KU Leuven)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I99464096","host_organization_name":"KU Leuven","host_organization_lineage":["https://openalex.org/I99464096"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/doctoralThesis"}],"best_oa_location":{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/683645","doi":null,"is_oa":true,"landing_page_url":"https://lirias.kuleuven.be/handle/123456789/683645","pdf_url":"https://lirias.kuleuven.be/retrieve/7c803b0a-f250-4d5c-a667-18b943422303","source":{"id":"https://openalex.org/S4306401954","display_name":"Lirias (KU Leuven)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I99464096","host_organization_name":"KU Leuven","host_organization_lineage":["https://openalex.org/I99464096"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/doctoralThesis"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2782884543","display_name":null,"funder_award_id":"1133220N","funder_id":"https://openalex.org/F4320321730","funder_display_name":"Fonds Wetenschappelijk Onderzoek"},{"id":"https://openalex.org/G3214598188","display_name":null,"funder_award_id":"C22/15/024","funder_id":"https://openalex.org/F4320322308","funder_display_name":"KU Leuven"},{"id":"https://openalex.org/G4385411488","display_name":"Optimized muscle-specific expression and comprehensive characterization of antibody-encoding minicircles for the in vivo production of therapeutic antibodies in mice","funder_award_id":"G0E2117N","funder_id":"https://openalex.org/F4320321730","funder_display_name":"Fonds Wetenschappelijk Onderzoek"}],"funders":[{"id":"https://openalex.org/F4320313460","display_name":"Agentschap Innoveren en Ondernemen","ror":"https://ror.org/032xdry56"},{"id":"https://openalex.org/F4320321730","display_name":"Fonds Wetenschappelijk Onderzoek","ror":"https://ror.org/03qtxy027"},{"id":"https://openalex.org/F4320322308","display_name":"KU Leuven","ror":"https://ror.org/05f950310"},{"id":"https://openalex.org/F4320327336","display_name":"Vlaamse regering","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7010444935.pdf","grobid_xml":"https://content.openalex.org/works/W7010444935.grobid-xml"},"referenced_works_count":118,"referenced_works":["https://openalex.org/W264975424","https://openalex.org/W1062587256","https://openalex.org/W1913328895","https://openalex.org/W1967995370","https://openalex.org/W1982236072","https://openalex.org/W1994993231","https://openalex.org/W2001248362","https://openalex.org/W2001705172","https://openalex.org/W2004630197","https://openalex.org/W2020026758","https://openalex.org/W2023071514","https://openalex.org/W2025459290","https://openalex.org/W2045882462","https://openalex.org/W2057377546","https://openalex.org/W2094366129","https://openalex.org/W2097995306","https://openalex.org/W2101581360","https://openalex.org/W2112196468","https://openalex.org/W2112601576","https://openalex.org/W2121080857","https://openalex.org/W2124002866","https://openalex.org/W2129244956","https://openalex.org/W2133075384","https://openalex.org/W2166470661","https://openalex.org/W2307564614","https://openalex.org/W2412051818","https://openalex.org/W2467885539","https://openalex.org/W2503880845","https://openalex.org/W2515494400","https://openalex.org/W2516271598","https://openalex.org/W2549925369","https://openalex.org/W2587048937","https://openalex.org/W2590333360","https://openalex.org/W2603690292","https://openalex.org/W2621841059","https://openalex.org/W2626337750","https://openalex.org/W2743419024","https://openalex.org/W2756035269","https://openalex.org/W2756467165","https://openalex.org/W2767045610","https://openalex.org/W2774511679","https://openalex.org/W2778445562","https://openalex.org/W2781632821","https://openalex.org/W2783070348","https://openalex.org/W2783137027","https://openalex.org/W2786712411","https://openalex.org/W2787292387","https://openalex.org/W2791483720","https://openalex.org/W2792638493","https://openalex.org/W2793266847","https://openalex.org/W2793375933","https://openalex.org/W2794627893","https://openalex.org/W2801612216","https://openalex.org/W2801821552","https://openalex.org/W2808750176","https://openalex.org/W2893901087","https://openalex.org/W2894919607","https://openalex.org/W2895436565","https://openalex.org/W2900174742","https://openalex.org/W2904099327","https://openalex.org/W2904482058","https://openalex.org/W2904723051","https://openalex.org/W2909301717","https://openalex.org/W2914345456","https://openalex.org/W2920817121","https://openalex.org/W2937887082","https://openalex.org/W2940091041","https://openalex.org/W2946620483","https://openalex.org/W2948123668","https://openalex.org/W2959535874","https://openalex.org/W2963686803","https://openalex.org/W2967139876","https://openalex.org/W2973257820","https://openalex.org/W2973445191","https://openalex.org/W2976744492","https://openalex.org/W2980593108","https://openalex.org/W2982068004","https://openalex.org/W2986633517","https://openalex.org/W2999858469","https://openalex.org/W3003217347","https://openalex.org/W3005597080","https://openalex.org/W3006664585","https://openalex.org/W3009535944","https://openalex.org/W3011360311","https://openalex.org/W3011544836","https://openalex.org/W3012532724","https://openalex.org/W3023565412","https://openalex.org/W3023745224","https://openalex.org/W3027862477","https://openalex.org/W3028523516","https://openalex.org/W3036371943","https://openalex.org/W3037506839","https://openalex.org/W3039087845","https://openalex.org/W3039168692","https://openalex.org/W3043703771","https://openalex.org/W3046042268","https://openalex.org/W3059021172","https://openalex.org/W3091646782","https://openalex.org/W3098813693","https://openalex.org/W3102229501","https://openalex.org/W3102899245","https://openalex.org/W3104249075","https://openalex.org/W3105655002","https://openalex.org/W3107896279","https://openalex.org/W3114842160","https://openalex.org/W3118909178","https://openalex.org/W3124047768","https://openalex.org/W3126330113","https://openalex.org/W3127852329","https://openalex.org/W3128646645","https://openalex.org/W3134711195","https://openalex.org/W3152878368","https://openalex.org/W3153661026","https://openalex.org/W3182223936","https://openalex.org/W3212582257","https://openalex.org/W4232939899","https://openalex.org/W4253193856","https://openalex.org/W4255130209"],"related_works":["https://openalex.org/W3005597080","https://openalex.org/W2565450782","https://openalex.org/W2895762589","https://openalex.org/W2887881331","https://openalex.org/W4366207894","https://openalex.org/W4400056902","https://openalex.org/W2773106490","https://openalex.org/W3083173154","https://openalex.org/W2773617501","https://openalex.org/W2627028493"],"abstract_inverted_index":{"Immune":[0],"checkpoint":[1,75,431,518,588],"inhibitors":[2,589],"have":[3,18],"emerged":[4],"as":[5,13,139,188,243,305,399,614,616],"a":[6,34,51,113,164,167,171,312,445,463,634],"new":[7],"promising":[8,643],"treatment":[9,442,582],"modality":[10],"for":[11,112,217,268,308,353,365,472],"cancer,":[12],"these":[14,86],"monoclonal":[15],"antibodies":[16],"(mAbs)":[17],"been":[19,124],"shown":[20,190],"to":[21,42,50,57,103,159,211,348,411,507,512,557,637],"enable":[22],"durable":[23],"responses":[24,398,505],"in":[25,54,110,133,191,265,279,293,344,376,395,454,532,547,562,617],"patients":[26,39],"with":[27,74,126,131,276,583,619],"various":[28],"advanced":[29],"and":[30,106,141,170,233,274,297,301,316,322,337,350,357,370,387,414,457,479,498,502,511,540,590],"metastatic":[31],"tumors.":[32,549],"Still,":[33],"large":[35],"proportion":[36],"of":[37,45,69,116,150,195,199,215,252,326,333,383,428,459,476,492,515,523,543,597,609,624,641],"cancer":[38],"are":[40,262],"refractory":[41],"this":[43,90,151,206],"type":[44],"immunotherapy,":[46],"which":[47,554],"has":[48,122],"led":[49],"surging":[52],"interest":[53],"combination":[55,62,491,514,618],"treatments":[56],"improve":[58,247],"response":[59,577],"rates.":[60],"These":[61],"treatments,":[63],"however,":[64],"further":[65],"increase":[66,531],"the":[67,94,98,101,108,148,160,200,248,266,277,284,334,354,377,384,400,425,429,435,440,473,480,488,493,513,524,563,570,586,595,598,639],"risk":[68,427],"severe":[70],"immune-related":[71],"toxicity":[72,426],"associated":[73],"inhibitors.":[76,432,519],"We":[77],"hypothesized":[78],"that":[79,261,419,646],"intratumoral":[80,196,218,269,290,420,469,567,625,654],"antibody":[81,119,220],"gene":[82,120,135,221,328,421,470,626,629],"transfer":[83,121,422],"can":[84,179,184,423,632],"address":[85],"specific":[87],"challenges.":[88],"In":[89,205,283,485,569,602],"approach,":[91],"one":[92],"administers":[93],"mAb-encoding":[95],"nucleotides":[96],"into":[97],"tumor,":[99],"enabling":[100],"body":[102],"locally":[104],"produce":[105],"secrete":[107],"mAbs":[109,225,478],"vivo":[111,134],"prolonged":[114,296],"period":[115],"time.":[117],"Intratumoral":[118,381],"repeatedly":[123],"reported":[125],"viral":[127],"vectors,":[128],"yet":[129],"data":[130],"other":[132,161,620,642],"delivery":[136,198,475,608],"platforms,":[137,162],"such":[138],"mRNA":[140],"plasmid":[142],"DNA":[143],"(pDNA),":[144],"were":[145,241,320,374,408,579],"lacking":[146],"at":[147,366],"start":[149],"PhD":[152,207],"project.":[153],"pDNA":[154,270],"offers":[155],"several":[156],"advantages":[157],"compared":[158,257,506],"including":[163],"lower":[165,413],"immunogenicity,":[166],"higher":[168],"stability":[169],"less":[172],"complex":[173],"manufacturing":[174],"process.":[175],"The":[176,520],"resulting":[177,343],"expression":[178,338,542],"be":[180,186,648],"more":[181,294,416],"moderate,":[182],"but":[183],"still":[185],"effective,":[187,606],"e.g.":[189],"multiple":[192],"clinical":[193],"trials":[194],"DNA-based":[197,219,313,317,385,489,508,517,587,591,610],"cytokine":[201,481],"interleukin":[202],"12":[203],"(IL-12).":[204],"project,":[208],"we":[209,255,467,604],"aimed":[210],"demonstrate":[212],"preclinical":[213],"proof":[214],"concept":[216],"transfer.":[222],"Two":[223],"checkpoint-inhibiting":[224,477,611],"targeting":[226],"cytotoxic":[227],"T":[228,534,538],"lymphocyte-associated":[229],"protein":[230,237],"4":[231,349],"(CTLA-4)":[232],"programmed":[234],"cell":[235],"death":[236],"1":[238],"(PD-1),":[239],"respectively,":[240],"used":[242],"model":[244],"therapeutics.":[245],"To":[246],"low":[249,436],"transfection":[250,259,306],"efficiency":[251],"naked":[253],"pDNA,":[254],"first":[256],"two":[258],"methods":[260],"already":[263],"applied":[264],"clinic":[267],"delivery,":[271],"i.e.":[272],"electroporation":[273,291],"complexation":[275],"polycation":[278],"vivo-jetPEI":[280],"(Chapter":[281,330,403,483],"3).":[282],"syngeneic":[285,571],"MC38":[286,378],"mouse":[287],"tumor":[288,372,379,464,573],"model,":[289,574],"resulted":[292,394],"robust,":[295],"tumor-specific":[298],"reporter":[299],"expression,":[300,342],"was":[302,527,560],"therefore":[303],"selected":[304],"method":[307],"subsequent":[309],"experiments.":[310],"Next,":[311],"anti-CTLA-4":[314,355,386,496],"mAb":[315,319,335,341,356,361,405,438,497],"anti-PD-1":[318,358,388,494],"designed":[321],"validated":[323],"by":[324,450,529,622],"means":[325,623],"intramuscular":[327,401],"electrotransfer":[329,382,471],"4).":[331,404],"Engineering":[332],"sequences":[336],"cassette":[339],"improved":[340,500],"plasma":[345,406],"concentrations":[346],"up":[347,410],"14":[351],"\u00b5g/mL":[352],"mAb,":[359,495],"respectively.":[360],"levels":[362,407,655],"remained":[363],"detectable":[364],"least":[367],"six":[368],"months,":[369],"significant":[371],"regressions":[373],"obtained":[375],"model.":[380],"mAbs,":[389,612],"either":[390,566],"alone":[391,510,613],"or":[392,651],"combined,":[393],"similar":[396],"anti-tumor":[397,447,504],"route":[402],"however":[409],"70-fold":[412],"substantially":[415],"transient,":[417],"suggesting":[418],"reduce":[424],"expressed":[430],"Importantly,":[433],"despite":[434],"systemic":[437,446,503],"exposure,":[439],"local":[441,501,525],"did":[443],"trigger":[444],"response,":[448],"illustrated":[449],"moderate":[451],"abscopal":[452],"effects":[453,526],"contralateral":[455],"tumors":[456],"protection":[458],"cured":[460],"mice":[461],"against":[462],"rechallenge.":[465],"Finally,":[466],"evaluated":[468],"simultaneous":[474],"IL-12":[482,499,509,592],"5).":[484],"MC38-bearing":[486],"mice,":[487],"triple":[490,600],"both":[516],"immune-mediated":[521],"nature":[522],"confirmed":[528],"an":[530],"tumor-infiltrating":[533],"cells,":[535,539],"especially":[536],"CD8+":[537,544],"upregulated":[541],"effector":[545],"markers":[546],"electroporated":[548],"No":[550],"general":[551],"immune":[552],"activation,":[553],"could":[555],"lead":[556],"adverse":[558],"events,":[559],"detected":[561],"spleen":[564],"following":[565,581],"treatment.":[568],"B16F10":[572],"high":[575],"complete":[576],"rates":[578],"observed":[580],"control":[584],"plasmids,":[585],"alone,":[593],"hampering":[594],"evaluation":[596],"respective":[599],"combination.":[601],"conclusion,":[603],"demonstrated":[605],"localized":[607],"well":[615],"biologicals,":[621],"electrotransfer.":[627],"This":[628],"therapy":[630],"approach":[631],"present":[633],"suitable":[635],"platform":[636],"facilitate":[638],"development":[640],"(combination)":[644],"therapies":[645],"might":[647],"too":[649],"toxic":[650],"reach":[652],"insufficient":[653],"when":[656],"delivered":[657],"systemically.":[658]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7010444935","counts_by_year":[],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2025-10-10T00:00:00"}
